000			03576nam a22003975i 4500
999			_c86853 _d86853 _x1
001			86853
003			ES-MaUEC
005			20230202105415.0
007			cr nn 008mamaa
008			160527s2016 si | s |||| 0|eng d
020			_a9789811009891
040			_aES-MaUEC
050		4	_aQH315 _b.B364 2016 EB
082	0	4	_a612.028
082	0	4	_a571.538
090			_aQH315 _b.B364 2016
100	1		_aBanerjee, Ena Ray. _985925 _0Local
245	1	0	_aPerspectives in Translational Research in Life Sciences and Biomedicine : _bTranslational Outcomes Research in Life Sciences and Translational Medicine, Volume 1 _cby Ena Ray Banerjee
260			_aSingapore _bSpringer _c2016
300			_a1 recurso en línea (XII, 270 p.) 169 il., 148 il. col.
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
338			_aonline resource _bcr _2rdacarrier
505	0		_aChapter 1. Translational Research in Life Sciences -- Chapter 2. Preclinical disease models as a platform for drug discovery -- Chapter 3. Novel antibodies as a replacement for antibiotics -- Chapter 4. Functional Food and Nutraceuticals -- Chapter 5. Bio-Green-Technology as a multi-disciplinary interface amongst the Life Sciences.
520			_aThe present book addresses the multi-disciplinary nature of Translational Outcomes Research, which is a watershed for nearly all the disciplines of Life and Health Sciences, along with the Materials Sciences including but not limited to Zoology, Botany, Microbiology, Biochemistry, Physiology, Nanotechnology, the Medical Sciences, Bioengineering, Biophysics, Medicinal Chemistry, Structural Biology, Biostatistics and Bioinformatics. This book, for the first time, addresses the basic premises of fundamental research in facilitating drug discovery. One chapter is dedicated to a novel generation of platforms with novel camelid antibodies and their technological extensions, while another focuses on functional food and nutraceuticals. The book begins with a thorough overview of what translational outcomes research connotes and what the current status of research in the area is, and goes on to elucidate various pertinent preclinical disease models and their uses in basic and application based research in the Life Sciences. How basic approaches to screening and characterization vis-à-vis their role in amelioration of the two cardinal problems of inflammation and degeneration involved in most diseases is elucidated. The book ends with a discussion of the relevance and importance of using Bio Green technology in Translational Outcomes, addressing the need to fill the gap between academia and industry and clinics that can arise through direct or indirect collaboration between the stakeholders and emphasizing the need for an eco-friendly approach so as not to jeopardize the fine balance that holds life on earth in harmony.
650	0	7	_9495993 _aCiencias de la vida _2embne
650	0	7	_aTerapia genética _9150702 _0LocalX _2embne
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-981-10-0989-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9789811009891
907			_a.b12961310 _b10-10-17 _c21-11-16
942			_2lcc _cLE
945			_aQH315 .B364 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11616623 _z30-06-17
988	0	0	_aEBOOK, EBSPRINGER
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gsi _h0